Sarah P Huepenbecker

9PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Disease surveillancePredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 01, 2024
Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer.

Sarah Huepenbecker, Larissa A Meyer, Miranda Craft

|Dec 20, 2023
Evaluation of a tiered opioid prescription algorithm in an ERAS pathway: exploring opportunities for further refinement.

M Sol Basabe, Tina S Suki, Mark F Munsell

|Oct 06, 2022
Patient outcomes and adherence to an enhanced recovery pathway for open gynecologic surgery: a 6-year single-center experience.

Judy Hayek, Andres Zorrilla-Vaca, Larissa A Meyer

|Sep 27, 2022
Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States.

Sarah P Huepenbecker, Charlotte C Sun, Shuangshuang Fu

|Jul 08, 2022
Impact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer.

Sarah Huepenbecker, María Clara Santía, Ross Harrison

|Mar 25, 2022
Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States.

Sarah P Huepenbecker, Charlotte C Sun, Shuangshuang Fu

Pageof 2